このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effectiveness of Online Gut-Directed Hypnotherapy and Movement Motivational and Self-management Training for Abdominal Pain Disorders in Adolescents (HIPMO)

2026年11月12日 更新者:János Major、Bethesda Children's Hospital

Effectiveness of Online Hypnotherapy and Movement Motivation Training for Abdominal Pain Disorders in Adolescents

The present study is an online-based investigation involving adolescents with abdominal pain disorders, defined as recurrent abdominal pain persisting for at least two months. The study aims to evaluate the feasibility, acceptability, and effectiveness of online therapeutic interventions in comparison with usual pediatric gastroenterological care.

The study has two primary objectives. The first is to make two therapeutic interventions-Movement Motivation and Self-management Training (M3 Training) and gut-directed hypnotherapy-available online in Hungarian to young people with abdominal pain disorders and their families. Providing these interventions in an online format may facilitate easier and more timely access to therapeutic support for adolescents experiencing abdominal symptoms.

The second objective is to evaluate the effectiveness of the two online interventions. Specifically, the effectiveness of M3 Training and gut-directed hypnotherapy will be assessed both as individual interventions and in combination, and compared with usual pediatric gastroenterological care. This evaluation will assess whether the online interventions, delivered individually or in combination, offer effective therapeutic options for adolescents with abdominal pain disorders, focusing on both primary and secondary outcomes.

調査の概要

状態

まだ募集していません

条件

研究の種類

介入

入学 (推定)

800

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Budapest
      • Budapest、Budapest、ハンガリー、1146
        • HRC Bethesda Children's Hospital
        • 副調査官:
          • Katalin Forgács-Kristóf, MSc
        • コンタクト:
        • 副調査官:
          • Adrienn Vargay, PhD
        • 副調査官:
          • Sára Bencsik, MD
        • 副調査官:
          • Nándor Hajdú, PhD
        • 副調査官:
          • Katalin Eszter Müller, MD, PhD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

12年~18年 (子、大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

Following the minimum diagnostic work-up performed by a gastroenterologist, including:

  • celiac disease serology;
  • C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR);
  • complete blood count (CBC);
  • total protein;
  • albumin;
  • aspartate aminotransferase (AST; GOT);
  • alanine aminotransferase (ALT; GPT);
  • gamma-glutamyl transferase (GGT);
  • lactate dehydrogenase (LDH);
  • alkaline phosphatase (ALP);
  • urea;
  • creatinine;
  • iron studies;
  • urinalysis, at minimum using a urine dipstick;
  • fecal calprotectin or fecal occult blood testing.

Participants will be included in the study based on symptoms consistent with abdominal pain disorders according to the Rome V criteria and the following inclusion criteria:

  • Continuous or regularly recurrent abdominal pain persisting for at least 3 months.
  • No identifiable underlying organic disease that could explain the abdominal pain.
  • Able to care for themselves, capable of self-care and able to understand and follow the study procedures.
  • Able to read and write in Hungarian.
  • Has access to the internet.

Exclusion Criteria:

  • Known severe psychiatric disorder
  • Epilepsy
  • Gastrointestinal disease requiring treatment and associated with pain symptoms
  • Proctalgia fugax
  • Intellectual disability.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
介入なし:Standard care

In the standard care control group, as in the intervention groups, participants will use an online platform (hasifajdalomkezeles.hu) to record their adherence to the treatment recommended by their gastroenterologist. The website does not include any therapeutic videos or active intervention. Its sole function is to support repeated online questionnaire-based data collection assessing treatment fidelity, adherence, and perceived effectiveness of the treatment.

The primary and secondary outcome questionnaires become available at predefined time points over a 12-week period.

実験的:Gut-Focused Hypnosis Program

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis (www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis ( www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

実験的:M3 Training

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (hasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (fasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

実験的:Combined Hypnosis + M3 Training

This arm represents an integrated version of the hypnosis program and M3 Training, combining the two existing interventions into a single 12-week online program. Users access both therapeutic components through the same website (hasifajdalomkezeles.hu). During the 12-week-long joint program the hypnosis-related content and the M3 Training videos are released according to a coordinated schedule. The aim is not simply to provide the two interventions in parallel, but to achieve structured integration, ensuring that the two approaches complement one another.

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis ( www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (fasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Pain intensity (proportion of patients with ≥30% improvement in abdominal pain) measured by Numerical Rating Scale
時間枠:From enrollment to the end of treatment at 12 weeks.

≥30% reduction in pain intensity is our main outcome. Pain intensity will be assessed using an 11-point Numerical Rating Scale (NRS; 0-10), which is a validated measure of self-reported pain intensity in children and adolescents (Miró et al., 2009).

From enrollment to the end of treatment at 12 weeks.
Quality of Life measured by The Pediatric Quality of Life Inventory
時間枠:From enrollment to the end of treatment at 12 weeks

The Pediatric Quality of Life Inventory (PedsQL) is a validated questionnaire designed to assess health-related quality of life in children and adolescents.

From enrollment to the end of treatment at 12 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Functional Disability assessed by Functional Disability Inventory
時間枠:From enrollment to the end of treatment at 12 weeks

The Functional Disability Inventory (FDI) is a 15-item self-report measure assessing limitations in everyday physical, social, and school-related activities. It has been extensively validated in children and adolescents, including a large sample of 596 patients aged 8-17 years with chronic abdominal pain (Walker & Greene, 1991; Claar & Walker, 2006). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Anxiety and Depression measured by Revised Children's Anxiety and Depression Scale (RCADS)
時間枠:From enrollment to the end of treatment at 12 weeks

The Revised Children's Anxiety and Depression Scale (RCADS) is a 47-item self-report questionnaire assessing symptoms of anxiety and depression in children and adolescents and has demonstrated good psychometric properties in both community and clinical populations (Chorpita et al., 2000; Chorpita et al., 2005). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Gastrointestinal symptom-specific anxiety measured by Visceral Sensitivity Index
時間枠:From enrollment to the end of treatment at 12 weeks

The original Visceral Sensitivity Index (VSI) is a 15-item, unidimensional self-report questionnaire developed to assess gastrointestinal symptom-specific anxiety-that is, anxiety, worry, and fear related to gastrointestinal sensations, symptoms, and the situations in which these symptoms may occur. It was developed and validated in 96 adult patients with irritable bowel syndrome (IBS) and showed excellent reliability together with good content, convergent, divergent, and predictive validity (Labus et al., 2004). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Different cognitive, behavioural, and interpersonal strategies used by children to cope with pain assessed by Pain Coping Questionnaire
時間枠:From enrollment to the end of treatment at 12 weeks

The Pain Coping Questionnaire (PCQ) is a 39-item self-report measure assessing different cognitive, behavioural, and interpersonal strategies used by children to cope with pain. It was developed for children and adolescents and has been validated from approximately 8 years of age, including populations with recurrent pain (Reid et al., 1998). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Missing school days collected from parents
時間枠:From enrollment to the end of treatment at 12 weeks

School absence will be assessed as the parent-reported number of school days missed because of abdominal pain or gastrointestinal symptoms during a predefined recall period. Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Sleep characteristics assessed using study-specific self-report items
時間枠:From enrollment to the end of treatment at 12 weeks

Sleep characteristics will be assessed using study-specific self-report items covering perceived sleep quality, average nightly sleep duration, and frequency of daytime naps.

From enrollment to the end of treatment at 12 weeks
Intervention Satisfaction and Patient Global Impression of Change assessed by open-ended question
時間枠:From enrollment to the end of treatment at 12 weeks

Patient satisfaction will be explored using the following open-ended question: "What story would you tell your best friend about your experience with the therapy over the past 12 weeks?"

Patient Global Impression of Change will be measured through the following question:

Since the start of the study, my overall status is: options range from "Very Much Improved" to "Very Much Worse" Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Website engagement collected via webpage
時間枠:From enrollment to the end of treatment at 12 weeks

Website monitoring will include the number and timing of logins, the duration and frequency of listening to the audio recordings, the duration and frequency of viewing the M3 videos, whether each audio recording was listened to at least once, whether each video was viewed at least once, and whether all questions were answered; if not, the number and identity of unanswered questions will also be recorded.

From enrollment to the end of treatment at 12 weeks
Adequate Relief of Abdominal Pain and/or Discomfort assessed using a single dichotomous (yes/no) question.
時間枠:From enrollment to the end of treatment at 12 weeks

Proportion of participants reporting adequate relief of abdominal pain and/or discomfort during the preceding week compared with baseline, assessed using a single dichotomous (yes/no) question.

From enrollment to the end of treatment at 12 weeks

その他の成果指標

結果測定
メジャーの説明
時間枠
Adverse event assessed by open-ended questions
時間枠:From enrollment to the end of treatment at 12 weeks

Adverse events will be monitored prospectively throughout the intervention period. An adverse event will be defined as any new or worsening unfavourable physical or psychological health-related occurrence during study participation, irrespective of whether it is considered to be related to the intervention. At each scheduled assessment, participants will be asked about any new or worsening health-related problems since the previous assessment. If an adverse event is reported, a brief description of the event, its impact on daily activities, whether medical attention was required, and whether it resulted in modification or discontinuation of the intervention will be recorded. Reported events will subsequently be reviewed by the study team with respect to severity, seriousness, expectedness, and possible relatedness to the intervention (Junqueira et al., 2023; Burns et al., 2024). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月1日

一次修了 (推定)

2030年12月1日

研究の完了 (推定)

2030年12月1日

試験登録日

最初に提出

2026年11月12日

QC基準を満たした最初の提出物

2026年11月12日

最初の投稿 (実際)

2026年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月12日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • BM/9151-1/2024

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する